ASX - By Stock
|
ARX |
Re:
Marching towards $2 first then 1 billion market cap
|
|
win8
|
23 |
12K |
1 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
23
|
12K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Marching towards $2 first then 1 billion market cap
|
|
win8
|
23 |
12K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
23
|
12K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Marching towards $2 first then 1 billion market cap
|
|
win8
|
23 |
12K |
3 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
23
|
12K
|
3
|
|
ASX - By Stock
|
ARX |
Re:
Marching towards $2 first then 1 billion market cap
|
|
win8
|
23 |
12K |
1 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
23
|
12K
|
1
|
|
ASX - By Stock
|
ARX |
Marching towards $2 first then 1 billion market cap
|
|
win8
|
23 |
12K |
5 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
23
|
12K
|
5
|
|
ASX - By Stock
|
ARX |
Re:
tela bio
|
|
win8
|
2 |
1.1K |
2 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
2
|
1.1K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY23
|
|
win8
|
14 |
5.0K |
1 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
14
|
5.0K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Notification regarding unquoted securities - ARX
|
|
win8
|
2 |
876 |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
2
|
876
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY23
|
|
win8
|
14 |
5.0K |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
14
|
5.0K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY23
|
|
win8
|
14 |
5.0K |
0 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
14
|
5.0K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY23
|
|
win8
|
14 |
5.0K |
3 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
14
|
5.0K
|
3
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY23
|
|
win8
|
14 |
5.0K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
14
|
5.0K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
2 |
24/11/22 |
24/11/22 |
Charts
|
453
|
278K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
0 |
23/11/22 |
23/11/22 |
Charts
|
453
|
278K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
2 |
23/11/22 |
23/11/22 |
Charts
|
453
|
278K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
0 |
23/11/22 |
23/11/22 |
Charts
|
453
|
278K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
4 |
22/11/22 |
22/11/22 |
Charts
|
453
|
278K
|
4
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
22/11/22 |
22/11/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
0 |
21/11/22 |
21/11/22 |
Charts
|
453
|
278K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
0 |
21/11/22 |
21/11/22 |
Charts
|
453
|
278K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
16/11/22 |
16/11/22 |
Charts
|
453
|
278K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
0 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
27
|
7.4K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
27
|
7.4K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Becoming a substantial holder
|
|
win8
|
3 |
1.2K |
1 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Becoming a substantial holder
|
|
win8
|
3 |
1.2K |
5 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
3
|
1.2K
|
5
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
3 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
3
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
0 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
1 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
5 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
5
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
2 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
4 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
4
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
2 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: September 2022 Quarterly Report and Appendix 4C
|
|
win8
|
27 |
7.4K |
4 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
27
|
7.4K
|
4
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
06/10/22 |
06/10/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
2 |
16/09/22 |
16/09/22 |
Charts
|
453
|
278K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
2 |
14/09/22 |
14/09/22 |
Charts
|
453
|
278K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Dr Catherine Mohr to join Aroa Board
|
|
win8
|
1 |
849 |
2 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
1
|
849
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
09/09/22 |
09/09/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
06/09/22 |
06/09/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
06/09/22 |
06/09/22 |
Charts
|
453
|
278K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Change of Director's Interest Notice - JD
|
|
win8
|
1 |
629 |
0 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
1
|
629
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
5 |
26/08/22 |
26/08/22 |
Charts
|
453
|
278K
|
5
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
25/08/22 |
25/08/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
0 |
19/08/22 |
19/08/22 |
Charts
|
453
|
278K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
18/08/22 |
18/08/22 |
Charts
|
453
|
278K
|
1
|
|
ASX - By Stock
|
ARX |
Re:
Ann: CEO Presentation - AGM
|
|
win8
|
1 |
1.5K |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
1
|
1.5K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
1 |
11/08/22 |
11/08/22 |
Charts
|
453
|
278K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
2 |
08/08/22 |
08/08/22 |
Charts
|
453
|
278K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
win8
|
453 |
278K |
3 |
01/08/22 |
01/08/22 |
Charts
|
453
|
278K
|
3
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
win8
|
2 |
1.0K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|